Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 1/20 | 0.34 |
| ▸ | CASP3 | P42574 | 2/20 | 0.33 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.33 |
| ▸ | CDC37 | Q16543 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.33 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.33 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.33 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.33 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.33 |
| ▸ | THPO | P40225 | 1/20 | 0.33 |
| ▸ | ATM | Q13315 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.32 |
| ▸ | CA12 | O43570 | 1/20 | 0.32 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | CA9 | Q16790 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21264371 | 0.86 | ATM (0.35) | NPC1CASP3HSP90AB1CDC37CYP1A2 | |
| SCHEMBL18993804 | 0.84 | — | — | |
| SCHEMBL15198822 | 0.83 | ATM (0.32) | NPC1ATM | |
| SCHEMBL13780529 | 0.81 | NPC1 (0.33) | NPC1CASP3HSP90AB1CDC37CYP1A2 | |
| SCHEMBL20253641 | 0.81 | NPC1 (0.33) | NPC1CYP1A2CHRM2CHRM4CHRM5 | |
| SCHEMBL663919 | 0.80 | ATM (0.50) | CYP1A2NFKB1ATMLMNAPMP22 | |
| SCHEMBL10260787 | 0.77 | ATM (0.37) | CHRM1ATMLMNATSHR | |
| SCHEMBL20253607 | 0.76 | ATM (0.33) | NPC1CYP1A2CHRM2CHRM4CHRM5 | |
| SCHEMBL847892 | 0.75 | SMN1; SMN2 (0.36) | CASP3HSP90AB1CDC37ATMTSHR | |
| SCHEMBL14771785 | 0.75 | ATM (0.33) | ATM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 368 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260148977-A1 | Positive Electrode and Lithium Secondary Battery Including the Same | LG ENERGY SOLUTION, LTD. (KR) | 2026-05-28 | — | — | US | disclosed |
| CN-122051140-A | Lithium secondary battery | 株式会社LG新能源 | 2026-05-15 | — | — | CN | disclosed |
| CN-122051331-A | Lithium secondary battery, battery module and battery pack | 株式会社LG新能源 | 2026-05-15 | — | — | CN | disclosed |
| EP-4734175-A1 | POSITIVE ELECTRODE ACTIVE MATERIAL, AND POSITIVE ELECTRODE AND LITHIUM SECONDARY BATTERY COMPRISING SAME | LG Energy Solution, Ltd. (KR) | 2026-04-29 | — | — | EP | disclosed |
| EP-4276952-B1 | LITHIUM SECONDARY BATTERY | LG ENERGY SOLUTION LTD (KR) | 2026-02-04 | — | — | EP | disclosed |
| EP-4398375-B1 | LITHIUM SECONDARY BATTERY | LG ENERGY SOLUTION LTD (KR) | 2026-01-14 | — | — | EP | disclosed |
| EP-4579801-A1 | LITHIUM SECONDARY BATTERY | LG Energy Solution, Ltd. (KR) | 2025-07-02 | — | — | EP | disclosed |
| US-20250210658-A1 | Lithium Secondary Battery | LG ENERGY SOLUTION, LTD. (KR) | 2025-06-26 | — | — | US | disclosed |
| EP-4576258-A1 | POSITIVE ELECTRODE AND LITHIUM SECONDARY BATTERY INCLUDING SAME | LG Energy Solution, Ltd. (KR) | 2025-06-25 | — | — | EP | disclosed |
| US-20250192220-A1 | Lithium Secondary Battery | LG ENERGY SOLUTION, LTD. (KR) | 2025-06-12 | — | — | US | disclosed |
| US-20100217287-A1 | SELF-ASSEMBLING FIBROUS NETWORKS | SOFRADIM PRODUCTION (FR) | 2010-08-26 | — | — | US | disclosed |
| WO-2010095048-A2 | FUNCTIONALIZED ADHESIVE MEDICAL GEL | SOFRADIM PRODUCTION (FR) | 2010-08-26 | — | — | WO | disclosed |
| WO-2010095044-A2 | MEDICAL DEVICE WITH DEGRADATION-RETARDING COATING | SOFRADIM PRODUCTION (FR) | 2010-08-26 | — | — | WO | disclosed |
| US-20100212829-A1 | MEDICAL DEVICES INCORPORATING FUNCTIONAL ADHESIVES | SOFRADIM PRODUCTION (FR) | 2010-08-26 | — | — | US | disclosed |
| WO-2010095057-A1 | FIBERS WITH AN ACTIVATED SURFACE AND METHOD OF MAKING SAME BY EXTRUSION | SOFRADIM PRODUCTION (FR) | 2010-08-26 | — | — | WO | disclosed |
| WO-2010095045-A1 | AMPHIPHILIC COMPOUNDS AND SELF-ASSEMBLING COMPOSITIONS MADE THEREFROM | SOFRADIM PRODUCTION (FR) | 2010-08-26 | — | — | WO | disclosed |
| WO-2010095052-A2 | COMPOUNDS AND MEDICAL DEVICES ACTIVATED WITH SOLVOPHOBIC LINKERS | SOFRADIM PRODUCTION (FR) | 2010-08-26 | — | — | WO | disclosed |
| WO-2010095054-A2 | SELF-ASSEMBLING FIBROUS NETWORKS | SOFRADIM PRODUCTION (FR) | 2010-08-26 | — | — | WO | disclosed |
| WO-2010095046-A2 | MEDICAL DEVICES INCORPORATING FUNCTIONAL ADHESIVES | SOFRADIM PRODUCTION (FR) | 2010-08-26 | — | — | WO | disclosed |
| US-20100215748-A1 | FUNCTIONALIZED ADHESIVE MEDICAL GEL | SOFRADIM PRODUCTION (FR) | 2010-08-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260148977-A1 | Positive Electrode and Lithium Secondary Battery Including the Same | MNS1, LBR, MEF2D | NPC1 2021/4885CASP3 3537/4885HSP90AB1 3458/4885 |
| US-20100215748-A1 | FUNCTIONALIZED ADHESIVE MEDICAL GEL | ADGRE5, EPCAM, ADGRF1 | NPC1 4884/4885CASP3 3963/4885HSP90AB1 553/4885 |
| US-20100217287-A1 | SELF-ASSEMBLING FIBROUS NETWORKS | ILK, FGB, EPCAM | NPC1 4797/4885CASP3 2742/4885HSP90AB1 940/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.